X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs NATCO PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD NATCO PHARMA ALEMBIC LTD/
NATCO PHARMA
 
P/E (TTM) x 56.2 16.0 352.1% View Chart
P/BV x 2.3 17.2 13.6% View Chart
Dividend Yield % 0.4 0.7 65.4%  

Financials

 ALEMBIC LTD   NATCO PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
NATCO PHARMA
Mar-14
ALEMBIC LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs72877 8.2%   
Low Rs34424 8.0%   
Sales per share (Unadj.) Rs4.7223.4 2.1%  
Earnings per share (Unadj.) Rs6.131.1 19.6%  
Cash flow per share (Unadj.) Rs6.240.3 15.5%  
Dividends per share (Unadj.) Rs0.205.00 4.0%  
Dividend yield (eoy) %0.40.8 49.1%  
Book value per share (Unadj.) Rs40.7219.5 18.5%  
Shares outstanding (eoy) m267.0333.07 807.5%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x11.32.9 387.1%   
Avg P/E ratio x8.720.9 41.4%  
P/CF ratio (eoy) x8.516.1 52.5%  
Price / Book Value ratio x1.33.0 44.0%  
Dividend payout %3.316.1 20.4%   
Avg Mkt Cap Rs m14,13921,504 65.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2071,128 18.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,2557,389 17.0%  
Other income Rs m370167 221.5%   
Total revenues Rs m1,6257,556 21.5%   
Gross profit Rs m1111,793 6.2%  
Depreciation Rs m38304 12.4%   
Interest Rs m2366 0.5%   
Profit before tax Rs m4421,290 34.3%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24309 7.8%   
Profit after tax Rs m1,6301,027 158.6%  
Gross profit margin %8.924.3 36.5%  
Effective tax rate %5.423.9 22.6%   
Net profit margin %129.813.9 933.8%  
BALANCE SHEET DATA
Current assets Rs m1,8673,681 50.7%   
Current liabilities Rs m5913,123 18.9%   
Net working cap to sales %101.67.6 1,344.7%  
Current ratio x3.21.2 267.9%  
Inventory Days Days9489 105.3%  
Debtors Days Days7459 125.3%  
Net fixed assets Rs m1,7917,685 23.3%   
Share capital Rs m534331 161.5%   
"Free" reserves Rs m10,3246,670 154.8%   
Net worth Rs m10,8587,259 149.6%   
Long term debt Rs m41955 4.3%   
Total assets Rs m11,59111,957 96.9%  
Interest coverage x260.94.5 5,769.0%   
Debt to equity ratio x00.1 2.9%  
Sales to assets ratio x0.10.6 17.5%   
Return on assets %14.111.7 120.8%  
Return on equity %15.014.2 106.1%  
Return on capital %15.220.7 73.3%  
Exports to sales %1.539.4 3.9%   
Imports to sales %21.05.7 368.0%   
Exports (fob) Rs m192,908 0.7%   
Imports (cif) Rs m263421 62.5%   
Fx inflow Rs m193,445 0.6%   
Fx outflow Rs m264703 37.5%   
Net fx Rs m-2442,743 -8.9%   
CASH FLOW
From Operations Rs m2361,440 16.4%  
From Investments Rs m-224-1,089 20.6%  
From Financial Activity Rs m-27-353 7.5%  
Net Cashflow Rs m-15-1 993.3%  

Share Holding

Indian Promoters % 64.0 52.0 123.0%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.2 7.8 2.6%  
FIIs % 9.7 16.6 58.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 26.0 100.4%  
Shareholders   54,701 25,395 215.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   TORRENT PHARMA  ALEMBIC PHARMA  AJANTA PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare ALEMBIC LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 17, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS